Cargando…
Myasthenia gravis in clinical practice
BACKGROUND: Myasthenia gravis is largely a treatable disease, but it can result in significant morbidity and even mortality, which can usually be avoided, or at least mitigated, with timely diagnosis and appropriate treatment of the disease. Objective: this review aims to summarize the main practica...
Autores principales: | Estephan, Eduardo de Paula, Baima, José Pedro Soares, Zambon, Antonio Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia - ABNEURO
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491427/ https://www.ncbi.nlm.nih.gov/pubmed/35976295 http://dx.doi.org/10.1590/0004-282X-ANP-2022-S105 |
Ejemplares similares
-
The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022) -
Prognosis in Pediatric Myasthenia Gravis
por: Krueger, Jena
Publicado: (2020) -
Inflammatory myopathies: an update for neurologists
por: Silva, André Macedo Serafim, et al.
Publicado: (2022) -
Gene therapy in neuromuscular disorders
por: Mendonça, Rodrigo Holanda, et al.
Publicado: (2022) -
Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022)